BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9578705)

  • 21. Cyclooxygenase-2 in oligodendroglial neoplasms.
    Castilla EA; Prayson RA; Kanner AA; Rybicki LA; Tubbs RR; Vogelbaum MA; Barnett GH
    Cancer; 2003 Oct; 98(7):1465-72. PubMed ID: 14508834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second surgery and the prognosis of choroid plexus carcinoma--results of a meta-analysis of individual cases.
    Wrede B; Liu P; Ater J; Wolff JE
    Anticancer Res; 2005; 25(6C):4429-33. PubMed ID: 16334121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Choroid plexus tumours--an immunohistochemical analysis with review of literature.
    Radotra BD; Joshi K; Kak VK; Banerjee AK
    Indian J Pathol Microbiol; 1994 Jan; 37(1):9-19. PubMed ID: 7522222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Choroid plexus tumours: cytogenetic analysis of a single case and literature review].
    Farnedi A; Marucci G; Tosi AL; Magrini E; Pession A
    Pathologica; 2007 Dec; 99(6):424-7. PubMed ID: 18416333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathobiology of pituitary adenomas and carcinomas.
    Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
    Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression of cell cycle regulatory proteins in oligodendroglial tumors.
    Kamiya M; Nakazato Y
    Clin Neuropathol; 2002; 21(2):52-65. PubMed ID: 12005253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does choroid plexus tumour differ with age?
    Sampath S; Nitin G; Yasha TC; Chandramouli BA; Devi BI; Kovoor JM
    Br J Neurosurg; 2008 Jun; 22(3):373-88. PubMed ID: 18568726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.
    Ariga R; Zarif A; Korasick J; Reddy V; Siziopikou K; Gattuso P
    Breast J; 2005; 11(4):278-80. PubMed ID: 15982396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunocytochemical detection of insulin-like growth factor II (IGF-II) in choroid plexus papilloma: a possible marker for differential diagnosis.
    Kubo S; Ogino S; Fukushima T; Maruno M; Yoshimine T; Hasegawa H
    Clin Neuropathol; 1999; 18(2):74-9. PubMed ID: 10192701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical localization of the glucose transporter GLUT1 in choroid plexus papillomas.
    Kurosaki M; Hori T; Takata K; Kawakami H; Hirano H
    Noshuyo Byori; 1995 Mar; 12(1):69-73. PubMed ID: 7795732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival.
    Inagawa S; Itabashi M; Adachi S; Kawamoto T; Hori M; Shimazaki J; Yoshimi F; Fukao K
    Clin Cancer Res; 2002 Feb; 8(2):450-6. PubMed ID: 11839663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA methylation patterns of the CDH1, RARB, and SFN genes in choroid plexus tumors.
    Losi-Guembarovski R; Kuasne H; Guembarovski AL; Rainho CA; Cólus IM
    Cancer Genet Cytogenet; 2007 Dec; 179(2):140-5. PubMed ID: 18036402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poly(adenosine diphosphate-ribose) polymerase expression in serous ovarian carcinoma: correlation with p53, MIB-1, and outcome.
    Brustmann H
    Int J Gynecol Pathol; 2007 Apr; 26(2):147-53. PubMed ID: 17413981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic implications of atypical histologic features in choroid plexus papilloma.
    Jeibmann A; Hasselblatt M; Gerss J; Wrede B; Egensperger R; Beschorner R; Hans VH; Rickert CH; Wolff JE; Paulus W
    J Neuropathol Exp Neurol; 2006 Nov; 65(11):1069-73. PubMed ID: 17086103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic relevance of proliferative activity evaluated by Mib-1 immunostaining in node negative breast cancer.
    Neri A; Marrelli D; Pedrazzani C; Caruso S; De Stefano A; Mariani F; Megha T; De Marco G; Corso G; Pinto E; Roviello F
    Eur J Surg Oncol; 2008 Dec; 34(12):1299-303. PubMed ID: 18164172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
    Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
    Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors.
    Zamecnik J; Snuderl M; Eckschlager T; Chanova M; Hladikova M; Tichy M; Kodet R
    Mod Pathol; 2003 Oct; 16(10):980-91. PubMed ID: 14559980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathological and immunohistochemical studies of choroid plexus carcinoma of the dog.
    Cantile C; Campani D; Menicagli M; Arispici M
    J Comp Pathol; 2002; 126(2-3):183-93. PubMed ID: 11945007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunohistochemical study on distribution of transthyretin in normal human brain tissue and tumors].
    Kunishio K; Shiraishi T; Mishima N; Matsumi N; Tamiya T; Honda C; Matsumoto K; Furuta T; Nishimoto A
    No To Shinkei; 1989 Mar; 41(3):245-9. PubMed ID: 2667588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.
    Vis AN; Noordzij MA; Fitoz K; Wildhagen MF; Schröder FH; van der Kwast TH
    J Urol; 2000 Dec; 164(6):2156-61. PubMed ID: 11061947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.